Nordica’s Fibroid Care Centre has recorded more than 1,000 High-Intensity Focused Ultrasound (HIFU) treatments for fibroids and adenomyosis, marking five years since the centre began offering the technology in Nigeria.

The milestone was reached five years after the Fibroid Care Centre was established in 2021. Nordica says it became the first ultrasound-guided HIFU facility in Nigeria and West Africa, providing a non-invasive treatment option for appropriately selected patients with uterine fibroids and other benign uterine conditions.

The 1,000-treatment milestone was commemorated in Lagos, bringing together healthcare professionals, former patients, partners and other stakeholders to reflect on the centre’s experience with HIFU and the evolving approach to fibroid care.

Uterine fibroids are non-cancerous growths that develop in or around the uterus. Depending on their size and location, they can cause symptoms such as heavy or prolonged menstrual bleeding, pelvic pain, pressure and abdominal enlargement.

HIFU offers a non-invasive approach in which focused ultrasound energy is used to generate heat and target fibroid tissue under imaging guidance. Because the procedure does not require an open surgical incision, it can offer an alternative to some conventional surgical approaches for patients who meet the necessary medical criteria.

However, the treatment is not appropriate for everyone. Nordica says patients undergo specialist consultation and imaging to determine whether HIFU is suitable, with factors such as fibroid size, number and location considered alongside the patient's individual medical circumstances.

That patient-selection process is an important part of the significance of the centre’s five-year experience. The availability of specialised equipment alone does not guarantee access to the treatment; it also requires trained medical personnel, appropriate imaging, clinical assessment and follow-up care.

The centre has described its approach as one that gives women a range of treatment choices rather than presenting HIFU as a universal replacement for surgery.

The milestone also comes as technology continues to play a larger role in specialised women's healthcare in Nigeria. In August 2026, Nordica announced the donation of a HIFU machine to the Federal Capital Territory Administration during Abuja Reproductive Health Week, with the equipment intended to expand access to the technology in public healthcare.

The development represents a potential expansion of HIFU access beyond private specialist facilities, although the availability and use of the technology will depend on clinical capacity, patient assessment and the resources required to operate the equipment.

Nordica's experience also reflects growing interest in treatments that can reduce the need for invasive procedures in appropriately selected cases. Recent reporting on the centre's milestone noted that about 1,000 Nigerian women had undergone HIFU treatment, while Nordica's own website now records more than 1,000 treatments.

Patients whose experiences were shared during the milestone event described improvements following treatment, including reduced bleeding and abdominal swelling. Such individual experiences, however, should not be interpreted as evidence that every patient will experience the same outcome.

The broader challenge remains access. Advanced medical equipment, specialist expertise and diagnostic services can be expensive and are not equally available to women across Nigeria.

Nordica's milestone therefore provides a snapshot of the growing use of specialised technology in Nigeria's fibroid-care sector, while also highlighting the need for informed medical decision-making and wider access to quality gynaecological services.

As the Fibroid Care Centre moves beyond its first 1,000 HIFU treatments, its experience adds to the conversation about how non-invasive and minimally invasive technologies can complement existing approaches to fibroid and adenomyosis management in Nigeria.

Reporting by TalkNaijaMedia